News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Luye Pharma Group Ltd. To Stage $764 Million IPO In Hong Kong



6/23/2014 11:25:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Luye Pharma Group, headquartered in Shanghai, plans to raise as much as $764 million in a Hong Kong IPO next month. The diversified pharma, which was previously listed in Singapore, was taken private in 2012 in a transaction that valued the company at $513 million. The new IPO implies a value of $2.5 billion. The parties that participated in the go-private transactions – three private equity firms, the company’s chairman and the sovereign fund of Singapore – will sell shares in the IPO.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES